Drink and Drugs News DDN March 2020 | Page 3

UPFRONT IN THIS ISSUE Drink and Drugs News is published by CJ Wellings Ltd, Romney House, School Road, Ashford, Kent TN27 0LT t: 0845 299 3429 Editor: Claire Brown e: [email protected] Advertising manager: Ian Ralph e: [email protected] Reporter: David Gilliver e: [email protected] 8 Designer: Jez Tucker e: [email protected] Subscriptions: e: [email protected] website: www.drinkanddrugsnews.com Website support by wiredupwales.com Printed on environmentally friendly paper by the Manson Group Ltd Cover by proksima/iStock ON THE COVER: Heroin assisted treatment 16 National Naloxone Conversation REGULARS 4 NEWS Addiction psychiatry ‘could be wiped out’; alcohol admissions up 6 OUT OF COMMISSION Filling in for an absent alcohol strategy 10 A HELPING HAND Heroin-assisted treatment – transforming lives in Glasgow and Middlesbrough War on drugs complete failure Evaluating synthetic cannabinoid detox CJ Wellings Ltd does not accept responsibility for the accuracy of statements made by contributors or advertisers. The contents of this magazine are the copyright of CJ Wellings Ltd, but do not necessarily represent its views, or those of its partner organisations. 12 PROUD TO WORK IN PARTNERSHIP ‘The power of connection is what the DDN Conference is all about for us – a great big fat networking opportunity! A chance for our people to get motivated and share best practice, bringing new ideas back with us.’ Louise, The Arc (Ayriss Recovery Coventry CIC) DDN is a self-funded independent publication. Our bespoke partnership packages provide an opportunity to work closely with the magazine. Please get in touch to find out more. 14 ‘The savings offered by HAT give an obvious direction’ MANY YEARS AGO the UK treated heroin addiction as a medical issue, with diamorphine scripts dispensed by GPs. It’s taking us a long time to come back to that viewpoint but what might change the political mindset is the economic good sense of heroin assisted treatment (HAT, page 8). The savings represented by each person involved in the programme are significant and give an obvious direction. Hopefully the summits being held by the UK and Scottish governments (as we go to press) will not ignore the evidence from here and abroad. Investing in treatment programmes – that not only offer the appropriate medication but also essential ‘wraparound’ services – would have a powerful impact on these devastating statistics and a transformational effect on quality of life. A participant in the Middlesbrough HAT programme comments that he has tried all kinds of things over two decades, in and out of prison, and wasn’t expecting this to work ‘but then it was just unbelievable, how different it is.’ The GPs at their recent conference (page 12) also threw their weight behind this evidence-based harm reduction, so what are we waiting for? See you at our conference on 18 March! Claire Brown, editor Keep in touch at www.drinkanddrugsnews.com and @DDNmagazine WWW.DRINKANDDRUGSNEWS.COM MARCH 2020 • DRINK AND DRUGS NEWS • 3